Nirmacom generic Paxlovid, a COVID-19 oral medication developed by Hetero, has received WHO prequalification | Business Outreach

Nirmacom generic Paxlovid, a COVID-19 oral medication developed by Hetero

Hetero’s Nirmacom combo pack will comprise Nirmatrelvir 150 mg (2 pills) and Ritonavir 100mg (1 tablet).

Read More

Hetero’s Nirmacom combo pack will comprise Nirmatrelvir 150 mg (2 pills) and Ritonavir 100mg (1 tablet).

Read More

businessoutreach.in